- $13.02m
- $588.80m
- $82.98m
- 30
- 98
- 28
- 51
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49.7 | 130 | 146 | 44.4 | 83 |
Cost of Revenue | |||||
Gross Profit | 43.4 | 123 | 139 | 36.2 | 73.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 45.6 | 87.8 | 105 | 72.3 | 76.1 |
Operating Profit | 4.04 | 42.3 | 41.7 | -28 | 6.86 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.1 | 29.8 | 70.5 | -53.9 | 15.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.57 | 38.5 | 74 | -58.7 | 10.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.05 | 14.2 | 11.8 | -13.4 | -5.11 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.05 | 14.2 | 11.8 | -13.4 | -5.11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.81 | 3.8 | 6.91 | -9.43 | -3.38 |
Dividends per Share | |||||
Special Dividends per Share |